Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Wisp vs Zealthy

Wisp costs $187 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Wisp logo

Wisp

6.5
★★★☆☆3.3/5

Best for: an oral route if you will not self-inject

Visit Wisp →
VS
Zealthy logo

Zealthy

5.4
★★★☆☆2.7/5

Best for: coaching bundled into the price rather than sold separately

Visit Zealthy →

If you are choosing between Wisp and Zealthy, the first difference is cost: Wisp is $187 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Wisp leads our six-part score, 6.5 to 5.4. One of the two has an FDA warning letter on record, covered below.

Wisp vs Zealthy price

Wisp is the cheaper way in: $99 a month against $286 a month at Zealthy. That is $187 less each month (65% lower), or about $2,244 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Wisp ($225 a month vs $286 a month); tirzepatide is cheaper at Wisp ($99 a month vs $351 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Wisp prices compounded injections and brand-name pens, while Zealthy prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Wisp is the only one of the two with a brand-name price.

Where each one treats patients

Wisp does not publish where it ships, and Zealthy lists 34 states.

Pricing

Wisp

Compounded sublingual semaglutide drops 15mLCompounded
$225/mo
semaglutide
Metabolic Support & GLP-1 Boost capsules (adjunct supplement, not a prescription GLP-1)supplement subscription
$54/mo

Monthly subscription supplement, NOT a prescription GLP-1 medication. 'subscription' in form keeps it out of the GLP-1 hero price. drug omitted intentionally.

StartingBrand-name
$99/mo
tirzepatide

Zepbound $99/mo (compounded sublingual semaglutide $225/mo)

Zealthy

StartingCompounded
$286/mo
semaglutide

$151 medication + $135 monthly membership

StartingCompounded
$351/mo
tirzepatide

$216 medication + $135 monthly membership

What each price covers

Both prices cover shipping.

Wisp's price also covers the medication itself, which Zealthy does not claim.

Zealthy's price also covers the clinician visit and coaching, which Wisp does not claim.

Wisp is silent on the clinician visit, lab work and coaching.

Zealthy is silent on the medication itself and lab work.

That matters most for the drug: unless Zealthy confirms otherwise, budget for medication on top of its listed price.

Wisp

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Zealthy

Covered by the monthly price

Medication

Not stated

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, Wisp scores 6.5 and Zealthy 5.4 out of 10.

Wisp is stronger on value (3.5 vs 3.0), user experience (8.0 vs 3.0) and trust & safety (6.5 vs 3.0).

Zealthy is stronger on accessibility (7.4 vs 5.0) and support (5.5 vs 4.5).

Effectiveness is within half a point.

How we score

Wisp

6.5/10

Overall

Zealthy

5.4/10

Value25%

3.5A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.5A
vs
B
3.0

Accessibility10%

5.0A
vs
B
7.4

Support10%

4.5A
vs
B
5.5

FDA warning letters

Zealthy has 2 FDA warning letters on record.

Wisp has no FDA warning letter on record with us.

Features & Coverage

FeatureWispZealthy
Starting Price✓$99/mo$286/mo
Features✓8 features3 features
States AvailableNot disclosed34
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters✓None2 letters

About Wisp

$225/month buys a compounded sublingual semaglutide drops formulation from Wisp. Its weight care vertical also stocks three brand names: Saxenda, Zepbound, and Wegovy. A board-certified provider completes the review inside 24-72 hours. LegitScript certification is in place.

Read our full Wisp review →

About Zealthy

Active federal litigation and two FDA warning letters are disclosed in full; the entry exists here only for completeness, and the warnings and cons sections should be read before considering it. Zealthy sells compounded semaglutide and tirzepatide on an asynchronous telehealth model. FitRX, LLC is the legal entity, recently renamed Gronk Inc.

Read our full Zealthy review →

Pros & Cons

Wisp

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and shipping
  • We found no FDA warning letters issued to Wisp

Watch-outs

  • Semaglutide costs $225 a month, 22% above the $184 median for compounded semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Zealthy

What we like

  • The monthly price includes clinician visits, shipping and coaching

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Serves only 34 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Zealthy 2 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Wisp

Wisp wins this one, 6.5 to 5.4, above all for an oral route if you will not self-inject. It also costs $187 less each month than Zealthy. Zealthy fits better if coaching bundled into the price rather than sold separately is your priority.

Choose Wisp if…

You want an oral route if you will not self-inject and an opening price near $99 a month.

Choose Zealthy if…

You want coaching bundled into the price rather than sold separately and an opening price near $286 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.7

HealthRX

Compounded semaglutide at $133/month

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

Wisp vs Zealthy: FAQ

Wisp. It starts at $99 a month; Zealthy starts at $286 a month, $187 more per month.
Yes, both sell semaglutide and tirzepatide.
Wisp does not publish where it ships; Zealthy lists 34 states. Confirm your state before paying.
Both include shipping. Only Wisp includes the medication itself. Only Zealthy includes the clinician visit and coaching.
Wisp has none. Zealthy has 2 FDA warning letters on record.
No. Neither Wisp nor Zealthy pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.